Jiangsu, China

Yijun Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Neurodawn Pharmaceutical Co., Ltd., Simcere Pharmaceutical Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yijun Wang. Retrieved from https://idiyas.com/inventor/yijun-wang-qs158dob

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yijun Wang in Pharmaceutical Compositions

Introduction

Yijun Wang, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of pharmaceuticals. With a focus on innovative drug delivery methods, he has been recognized for his contributions to the development of effective pharmaceutical compositions.

Latest Patents

Wang holds a patent for a sublingual pharmaceutical composition that combines edaravone and (+)-2-borneol. This unique sublingual tablet pharmaceutical composition incorporates edaravone, along with (+)-2-camphanol, excipients, fillers, binders, disintegrants, and lubricants. The excipient choices include various compounds such as mannitol, lactose, dextran, cysteine, glycine, copovidone, and beta-cyclodextrin. This innovative approach to drug formulation aims to enhance the bioavailability and therapeutic effects of edaravone, making it more accessible for patient use.

Career Highlights

Throughout his career, Yijun Wang has worked with reputable pharmaceutical companies. Notably, he has been associated with Neurodawn Pharmaceutical Co., Ltd. and Simcere Pharmaceutical Co., Ltd., where he has leveraged his expertise to advance pharmaceutical research and development. His understanding of drug formulation and development has positioned him as a valuable asset in the industry.

Collaborations

Wang's collaborations with these companies have facilitated the exchange of knowledge and innovative ideas in the pharmaceutical sector. His work has contributed to the ongoing effort to innovate delivery systems for critical medications, affecting patient outcomes positively.

Conclusion

In summary, Yijun Wang's dedication to innovation in pharmaceutical compositions is evident through his patent and professional contributions. With ongoing efforts in drug formulation and his work with leading pharmaceutical companies, Wang continues to shape the future of pharmaceutical sciences in a meaningful way. His inventions not only enhance medication delivery but also represent a significant advancement in the treatment of various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…